154.03 USD
+2.02 (+1.32%)
AT CLOSE (11:59 AM EDT)
Novartis AG (NVS)
NYSE: NVS • USD
155.29
+1.34 (+0.87%)
POST MARKET (AS OF 07:59 PM EDT)
Market: CLOSED
Open?$153.37
High?$154.81
Low?$153.16
Prev. Close?$154.03
Volume?2.6M
Avg. Volume?2.5M
VWAP?$153.85
Rel. Volume?1.04x
Bid / Ask
Bid?$152.80 × 100
Ask?$157.99 × 100
Spread?$5.19
Midpoint?$155.40
Valuation & Ratios
Market Cap?293.9B
Shares Out?2.1B
P/E Ratio?60.36
P/B Ratio?3.92
EPS?$2.55
Dividend?2.20%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.12Adequate
Quick Ratio?0.84Weak
Cash Ratio?0.35Low
Debt/Equity?0.24Low
ValuationRICHLY VALUED
Score39/100
P/E?60.4PRICEY▾
P/B?3.92FAIR▾
P/S?7.88HIGH▾
P/FCF?36.0PRICEY▾
EV/EBITDA?51.0HIGH▾
EV/Sales?8.15HIGH▾
Returns & Efficiency
ROE?6.5%FAIR▾
ROA?3.7%FAIR▾
Cash Flow & Enterprise
FCF?$8.2B
Enterprise Value?$304.0B
Related Companies
Loading...
News
Profile
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.